Does Rallies show SBIO price targets?

Yes. Rallies tracks SBIO analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.

Is SBIO research on Rallies investment advice?

No. Rallies provides research, data, and educational context for SBIO. It does not provide personalized investment advice.

SBIO (ALPS Medical Breakthroughs ETF) Stock Analysis - Analyst Ratings

ALPS Medical Breakthroughs ETF (SBIO) is a publicly traded the market company. As of May 21, 2026, SBIO trades at $58.43 with a market cap of $0 and a P/E ratio of 0.00. SBIO moved +0.00% today. Year to date, SBIO is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $0.00 to $0.00. Rallies surfaces SBIO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate SBIO?

The average price target is $0.00.

SBIO Key Metrics

Key financial metrics for SBIO
Metric	Value
Price	$58.43
Market Cap	$0
P/E Ratio	0.00
EPS	$0.00
Dividend Yield	0.00%
52-Week High	$0.00
52-Week Low	$0.00
Volume	114.58K
Avg Volume	0
Revenue (TTM)	$0
Net Income	$0
Gross Margin	0.00%

SBIO Analyst Consensus

SBIO analyst coverage data. Average price target: $0.00.

Common questions about SBIO

What do analysts rate SBIO?: The average price target is $0.00.
Does Rallies show SBIO price targets?: Yes. Rallies tracks SBIO analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is SBIO research on Rallies investment advice?: No. Rallies provides research, data, and educational context for SBIO. It does not provide personalized investment advice.